Swasti Agro & Bioproducts Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.35 M
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 5.99%
- Profit Growth 13.06%
- Ebitda -25.75%
- Net Worth -21.10%
- Total Assets 37.85%
About Swasti Agro & Bioproducts
Swasti Agro & Bioproducts Private Limited (SABPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 May 2011 and has a history of 13 years and nine months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.35 M, as per Ministry of Corporate Affairs (MCA) records.
Abhay Shendye, Shobha Shendye, and Tejaswinee Shendye serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01400PN2011PTC139474
- Company No.
139474
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Swasti Agro & Bioproducts Private Limited offer?
Swasti Agro & Bioproducts Private Limited offers a wide range of products and services, including Batteries & Charge Storage Devices, Industrial and Automotive Battery Charger.
Who are the key members and board of directors at Swasti Agro & Bioproducts?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejaswinee Shendye  | Director | 22-May-2019 | Current |
| Abhay Shendye | Director | 15-Dec-2022 | Current |
| Shobha Shendye | Director | 27-Oct-2014 | Current |
Financial Performance of Swasti Agro & Bioproducts.
Swasti Agro & Bioproducts Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.99% increase. The company also saw a substantial improvement in profitability, with a 13.06% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swasti Agro & Bioproducts?
In 2019, Swasti Agro & Bioproducts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Swasti Agro & Bioproducts?
Unlock and access historical data on people associated with Swasti Agro & Bioproducts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swasti Agro & Bioproducts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swasti Agro & Bioproducts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
